These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Hypertriglyceridemic Waist: A Simple Marker of High-Risk Atherosclerosis Features Associated With Excess Visceral Adiposity/Ectopic Fat. LeBlanc S; Coulombe F; Bertrand OF; Bibeau K; Pibarot P; Marette A; Alméras N; Lemieux I; Després JP; Larose E J Am Heart Assoc; 2018 Apr; 7(8):. PubMed ID: 29654193 [TBL] [Abstract][Full Text] [Related]
4. Lipid deposition in various sites of the skeletal muscles and liver exhibits a positive correlation with visceral fat accumulation in middle-aged Japanese men with metabolic syndrome. Taira S; Shimabukuro M; Higa M; Yabiku K; Kozuka C; Ueda R; Sunagawa S; Ohshiro Y; Doi M; Nanba T; Kawamoto E; Nakayama Y; Nakamura H; Iha T; Nakachi S; Tomoyose T; Ikema T; Yamakawa K; Masuzaki H Intern Med; 2013; 52(14):1561-71. PubMed ID: 23857087 [TBL] [Abstract][Full Text] [Related]
5. Visceral obesity, but not central obesity, is associated with cardiac remodeling in subjects with suspected metabolic syndrome. Cho DH; Kim MN; Joo HJ; Shim WJ; Lim DS; Park SM Nutr Metab Cardiovasc Dis; 2019 Apr; 29(4):360-366. PubMed ID: 30782509 [TBL] [Abstract][Full Text] [Related]
6. Effects of magnitude of visceral adipose tissue reduction: Impact on insulin resistance, hyperleptinemia and cardiometabolic risk in adolescents with obesity after long-term weight-loss therapy. Campos RMDS; Masquio DCL; Corgosinho FC; Caranti DA; Ganen AP; Tock L; Oyama LM; Dâmaso AR Diab Vasc Dis Res; 2019 Mar; 16(2):196-206. PubMed ID: 30688518 [TBL] [Abstract][Full Text] [Related]
7. Abdominal obesity and the metabolic syndrome: contribution to global cardiometabolic risk. Després JP; Lemieux I; Bergeron J; Pibarot P; Mathieu P; Larose E; Rodés-Cabau J; Bertrand OF; Poirier P Arterioscler Thromb Vasc Biol; 2008 Jun; 28(6):1039-49. PubMed ID: 18356555 [TBL] [Abstract][Full Text] [Related]
8. Abdominal fat radiodensity, quantity and cardiometabolic risk: The Multi-Ethnic Study of Atherosclerosis. Shah RV; Allison MA; Lima JA; Abbasi SA; Eisman A; Lai C; Jerosch-Herold M; Budoff M; Murthy VL Nutr Metab Cardiovasc Dis; 2016 Feb; 26(2):114-22. PubMed ID: 26817938 [TBL] [Abstract][Full Text] [Related]
9. Adipose tissue at the crossroads in the development of the metabolic syndrome, inflammation and atherosclerosis. Wajchenberg BL; Nery M; Cunha MR; Silva ME Arq Bras Endocrinol Metabol; 2009 Mar; 53(2):145-50. PubMed ID: 19466206 [TBL] [Abstract][Full Text] [Related]
10. Visceral adiposity and the risk of metabolic syndrome across body mass index: the MESA Study. Shah RV; Murthy VL; Abbasi SA; Blankstein R; Kwong RY; Goldfine AB; Jerosch-Herold M; Lima JA; Ding J; Allison MA JACC Cardiovasc Imaging; 2014 Dec; 7(12):1221-35. PubMed ID: 25440591 [TBL] [Abstract][Full Text] [Related]
11. Ectopic fat deposition and global cardiometabolic risk: new paradigm in cardiovascular medicine. Shimabukuro M; Kozuka C; Taira S; Yabiku K; Dagvasumberel M; Ishida M; Matsumoto S; Yagi S; Fukuda D; Yamakawa K; Higa M; Soeki T; Yoshida H; Masuzaki H; Sata M J Med Invest; 2013; 60(1-2):1-14. PubMed ID: 23614905 [TBL] [Abstract][Full Text] [Related]
12. Pathophysiology of human visceral obesity: an update. Tchernof A; Després JP Physiol Rev; 2013 Jan; 93(1):359-404. PubMed ID: 23303913 [TBL] [Abstract][Full Text] [Related]
13. [Different adipose tissue depots and metabolic syndrome in human]. Wang R; Li XN Sheng Li Xue Bao; 2017 Jun; 69(3):357-365. PubMed ID: 28638930 [TBL] [Abstract][Full Text] [Related]
14. Influence of visceral obesity and liver fat on vascular structure and function in obese subjects. Sturm W; Sandhofer A; Engl J; Laimer M; Molnar C; Kaser S; Weiss H; Tilg H; Ebenbichler CF; Patsch JR Obesity (Silver Spring); 2009 Sep; 17(9):1783-8. PubMed ID: 19325543 [TBL] [Abstract][Full Text] [Related]
15. Ectopic fat and cardiometabolic and vascular risk. Lim S; Meigs JB Int J Cardiol; 2013 Nov; 169(3):166-76. PubMed ID: 24063931 [TBL] [Abstract][Full Text] [Related]
16. Metabolic syndrome and adipose tissue: new clinical aspects and therapeutic targets. Iannucci CV; Capoccia D; Calabria M; Leonetti F Curr Pharm Des; 2007; 13(21):2148-68. PubMed ID: 17627547 [TBL] [Abstract][Full Text] [Related]
17. Visceral adipose tissue indicates the severity of cardiometabolic risk in patients with and without type 2 diabetes: results from the INSPIRE ME IAA study. Smith JD; Borel AL; Nazare JA; Haffner SM; Balkau B; Ross R; Massien C; Alméras N; Després JP J Clin Endocrinol Metab; 2012 May; 97(5):1517-25. PubMed ID: 22337910 [TBL] [Abstract][Full Text] [Related]
18. Surrogate markers of visceral adiposity in young adults: waist circumference and body mass index are more accurate than waist hip ratio, model of adipose distribution and visceral adiposity index. Borruel S; Moltó JF; Alpañés M; Fernández-Durán E; Álvarez-Blasco F; Luque-Ramírez M; Escobar-Morreale HF PLoS One; 2014; 9(12):e114112. PubMed ID: 25479351 [TBL] [Abstract][Full Text] [Related]
19. The concept of metabolic syndrome: contribution of visceral fat accumulation and its molecular mechanism. Matsuzawa Y; Funahashi T; Nakamura T J Atheroscler Thromb; 2011; 18(8):629-39. PubMed ID: 21737960 [TBL] [Abstract][Full Text] [Related]
20. Metabolic obesity: the paradox between visceral and subcutaneous fat. Hamdy O; Porramatikul S; Al-Ozairi E Curr Diabetes Rev; 2006 Nov; 2(4):367-73. PubMed ID: 18220642 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]